Viewing Study NCT01044420


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT01044420
Status: UNKNOWN
Last Update Posted: 2010-01-07
First Post: 2010-01-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module